Medicare Advantage Exits Leave 10% of Seniors Scrambling for New Coverage in 2026
The promised land of ample choice in Medicare Advantage plans is shrinking, forcing millions to navigate a confusing, shrinking market.
The direct answer
The narrative of ever-expanding Medicare Advantage (MA) choices for seniors is facing a significant disruption. For 2026, up to 10% of MA enrollees, approximately 2.6 million people, are finding their current plans have been terminated, a notable increase from previous years
"About 13% of beneficiaries enrolled in individual MA-PDs this year (or about 2.6 million people) are in a plan that has been terminated for 2026, an increase from 2025 when nearly 1.3 million Medicare Advantage enrollees faced a termination."
. This trend sees major insurers exiting markets and trimming benefits, directly impacting beneficiaries who will need to find new coverage. Nationwide, the total number of individual MA plans available has decreased by 9% compared to 2025, with 3,373 plans offered for 2026
"In total, 3,373 Medicare Advantage plans, including those without prescription drug coverage, are available nationwide for individual enrollment in 2026 – a 9% decrease from the number of plans (346 fewer plans) offered in 2025."
. This contraction challenges the idea that seniors have an abundance of options, pushing them to re-evaluate their healthcare choices during a critical period of their lives. The Centers for Medicare & Medicaid Services (CMS) aims to improve payment accuracy and competition, but the reality on the ground for many seniors is a shrinking selection of plans
Today, CMS released the Calendar Year 2027 Medicare Advantage (MA) and Part D Rate Announcement to improve payment accuracy and competition across both programs. The finalized policies also advance CMS’ vision of a sustainable and stable MA program that offers high-quality…
— CMSGov link
.
The Shrinking Landscape of Choice
The illusion of boundless choice in Medicare Advantage is rapidly dissipating. For 2026, an estimated 13% of beneficiaries, or about 2.6 million individuals, are enrolled in plans that will cease to exist, a significant jump from last year's 1.3 million affected enrollees
"About 13% of beneficiaries enrolled in individual MA-PDs this year (or about 2.6 million people) are in a plan that has been terminated for 2026, an increase from 2025 when nearly 1.3 million Medicare Advantage enrollees faced a termination."
. This isn't a minor adjustment; it's a systemic contraction. The total number of MA plans available nationwide for individual enrollment has dropped by 9% to 3,373, down from 3,719 in 2025
"In total, 3,373 Medicare Advantage plans, including those without prescription drug coverage, are available nationwide for individual enrollment in 2026 – a 9% decrease from the number of plans (346 fewer plans) offered in 2025."
. This reduction means fewer options, potentially less competition driving down costs, and a greater challenge for seniors to find plans that meet their specific healthcare needs, especially those with chronic conditions requiring specialized care.
Behind the Exits: Profitability and Policy
Insurers' decisions to pull out of certain Medicare Advantage markets are driven by a complex interplay of financial incentives and regulatory environments. While the Centers for Medicare & Medicaid Services (CMS) aims to foster a sustainable MA program
Today, CMS released the Calendar Year 2027 Medicare Advantage (MA) and Part D Rate Announcement to improve payment accuracy and competition across both programs. The finalized policies also advance CMS’ vision of a sustainable and stable MA program that offers high-quality…
— CMSGov link
, the profitability of these plans can be squeezed by evolving payment rates and the cost of providing comprehensive benefits. For instance, the American College of Rheumatology (ACR) has urged CMS to strengthen provisions in the Inflation Reduction Act, expand biosimilar availability, and streamline prior authorization processes, suggesting that current MA structures can create hurdles for patient access to necessary treatments
"The American College of Rheumatology (ACR) recently submitted comments to the Centers for Medicare & Medicaid Services (CMS) on its calendar year (CY) 2026 proposed changes for Medicare Advantage Organizations (MAOs) and urged policymakers to codify measures in the Inflation Reduction Act, expand biosimilar availability in formularies, and streamline the prior authorization processes for MAOs."
. These industry pressures, often masked by corporate-speak like 'strategic realignment,' directly translate to fewer choices and potential benefit reductions for seniors.
What 'Termination' Really Means for You
When an insurer 'terminates' a Medicare Advantage plan, it doesn't just disappear into the ether. For those enrolled, it means their current plan will no longer be an option come January 1, 2026. This forces beneficiaries into a mandatory enrollment period to select a new plan. The challenge is compounded by the decreasing number of available plans, meaning the 'new' options might be fewer, more expensive, or offer less comprehensive coverage than their previous plan. It's a scramble to understand new networks, co-pays, and prescription drug formularies, often with limited support, turning a crucial healthcare decision into a high-stakes game of musical chairs.
Common mistakes
- Assuming all Medicare Advantage plans are identical.
Plans vary significantly in their coverage, networks, and costs. A termination impacts individuals differently based on their specific health needs and the benefits offered by their current plan versus available alternatives. - Focusing solely on the number of plans without considering quality or suitability.
A reduction in the number of plans is concerning, but the quality and appropriateness of the remaining plans for individual needs are paramount. A 'choice' that doesn't fit is no choice at all. - Overlooking the impact of provider network changes.
When plans change or are discontinued, seniors may find their preferred doctors or specialists are no longer in-network, necessitating a difficult transition to new providers.
Today, CMS released the Calendar Year 2027 Medicare Advantage (MA) and Part D Rate Announcement to improve payment accuracy and competition across both programs. The finalized policies also advance CMS’ vision of a sustainable and stable MA program that offers high-quality…
— CMSGov link
, but the reality for beneficiaries is a shrinking pool of options and the stressful task of finding new coverage. This isn't just a logistical inconvenience; it's a direct threat to the continuity of care for a vulnerable population, forcing them to navigate a system that prioritizes insurer bottom lines over patient stability. The narrative of choice is crumbling under the weight of market realities.
Frequently asked
What happens if my Medicare Advantage plan is discontinued?
If your Medicare Advantage plan is discontinued, you will typically receive a notification from your insurer. You will then be eligible for a Special Enrollment Period (SEP) to choose a new Medicare Advantage plan or switch back to Original Medicare. It is crucial to review your options during this SEP to ensure continuous coverage.
How can I find out if my plan is ending?
Insurers are required to notify beneficiaries in writing about plan terminations well in advance of the effective date. You should receive this notification from your plan provider. You can also check the Medicare.gov website or call Medicare directly for information about plan offerings in your area for 2026.
What should I look for in a new Medicare Advantage plan?
When choosing a new plan, consider the monthly premium, annual deductible, co-payments for doctor visits and hospital stays, prescription drug coverage (including specific drug costs), and the provider network. Ensure your preferred doctors and any specialists you see are included in the plan's network.
